Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001059383 | SCV001224007 | uncertain significance | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 2022-11-09 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PSTPIP1 protein function. ClinVar contains an entry for this variant (Variation ID: 854353). This variant has not been reported in the literature in individuals affected with PSTPIP1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 395 of the PSTPIP1 protein (p.Gly395Ser). |
Center for Genomics, |
RCV001059383 | SCV001468469 | uncertain significance | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 2021-03-30 | criteria provided, single submitter | clinical testing | PSTPIP1 NM_003978.4 exon 15 p.Gly395Ser (c.1183G>A): This variant has not been reported in the literature but is present in 0.04% (9/19522) of East Asian alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/15-77329449-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:854353). Evolutionary conservation suggests that this variant may impact the protein; computational predictive tools are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ambry Genetics | RCV002554419 | SCV003713028 | uncertain significance | Inborn genetic diseases | 2021-06-22 | criteria provided, single submitter | clinical testing | The c.1183G>A (p.G395S) alteration is located in exon 15 (coding exon 15) of the PSTPIP1 gene. This alteration results from a G to A substitution at nucleotide position 1183, causing the glycine (G) at amino acid position 395 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |